News


Apostle Inc Appoints Alexander Hartemink, PhD at Duke University to Scientific Advisory Board

Press release – Monday, February 12, 2018
For immediate release

MENLO PARK, CA, February 12, 2018 – Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. Dr. Hartemink is Professor of Computer Science and Biology at Duke University. He is the faculty director of the Office of Undergraduate Scholars and Fellows and the active member of Duke Center for Genomic and Computational Biology. He was also the former director of Graduate Program in Computational Biology and Bioinformatics (CBB). Dr. Hartemink received his PhD degree in Electrical Engineering and Computer Science (EECS) from MIT in 2001, MS degree in EECS from MIT in 1997, MPhil degree in Economics from Oxford in 1996, and BS in triple majors of Computer Science, Mathematics, and Economics from Duke University in 1994.

“I’m pleased to welcome Dr. Hartemink,” said David Ge, CEO and Chairman of Apostle. “Alex is a renowned leader in computational biology and machine learning and an achieved researcher with a wealth of experience and expertise in both AI algorithms and bioinformatics applications. His advice will add tremendous value to our company as we further our mission of bringing innovative technologies to help our community with the early detection of cancer and other potential clinical applications.”

Dr. Hartemink was the recipient of Alfred P. Sloan Fellowship and NSF Career award. His research at Duke focuses on many aspects of AI algorithms and their applications in genomics and biology.

Apostle news image

About Apostle Inc
Apostle Inc is a biotechnology company in Menlo Park, CA. It’s in the business of the research, development, licensing, and sales of novel technologies, and the related intellectual properties, products, and services for diagnosis and treatment of human diseases, to fundamentally improve the accuracy and efficiency of liquid biopsy - the testing of circulating free DNA (cfDNA) - in early cancer detection or other clinical applications such as noninvasive prenatal testing (NIPT), tests for infectious diseases, therapeutics including CAR-T.

More information can be found at www.apostlebio.com.
Contact: info@apostlebio.com